Joseph Romanelli - Net Worth and Insider Trading

Joseph Romanelli Net Worth

The estimated net worth of Joseph Romanelli is at least $2 Million dollars as of 2023-09-26. Joseph Romanelli is the President, Human Health Int?l of Merck & Co Inc and owns about 20,569 shares of Merck & Co Inc (MRK) stock worth over $2 Million. Details can be seen in Joseph Romanelli's Latest Holdings Summary section.

Transaction Summary of Joseph Romanelli


Joseph Romanelli Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joseph Romanelli owns 2 companies in total, including Merck & Co Inc (MRK) , and Merck & Co Inc (MRKPRB.PFD) .

Click here to see the complete history of Joseph Romanelli’s form 4 insider trades.

Insider Ownership Summary of Joseph Romanelli

Ticker Comapny Transaction Date Type of Owner
MRK Merck & Co Inc 2022-07-18 President & Human Health Int?l
MRKPRB.PFD Merck & Co Inc 2022-07-18 President & Human Health Int?l

Joseph Romanelli Latest Holdings Summary

Joseph Romanelli currently owns a total of 1 stock. Joseph Romanelli owns 20,569 shares of Merck & Co Inc (MRK) as of August 2, 2023, with a value of $2 Million.

Latest Holdings of Joseph Romanelli

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MRK Merck & Co Inc 2023-08-02 20,569 105.43 2,168,590

Holding Weightings of Joseph Romanelli

Joseph Romanelli Form 4 Trading Tracker

According to the SEC Form 4 filings, Joseph Romanelli has made a total of 4 transactions in Merck & Co Inc (MRK) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Merck & Co Inc is the sale of 89 shares on August 2, 2023, which brought Joseph Romanelli around $9,556.

Insider Trading History of Joseph Romanelli

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joseph Romanelli Trading Performance

GuruFocus tracks the stock performance after each of Joseph Romanelli's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph Romanelli is -5.55%. GuruFocus also compares Joseph Romanelli's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph Romanelli within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Joseph Romanelli's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Joseph Romanelli

Average Relative Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) -2.08 -5.55
Relative Return to S&P 500(%) -5.76 -18.14

Joseph Romanelli Ownership Network

Ownership Network List of Joseph Romanelli

No Data

Ownership Network Relation of Joseph Romanelli

Joseph Romanelli Owned Company Details

What does Merck & Co Inc do?

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Who are the key executives at Merck & Co Inc?

Joseph Romanelli is the President & Human Health Int?l of Merck & Co Inc. Other key executives at Merck & Co Inc include Chief Marketing Officer Chirfi Guindo , SVP Human Health Global Mktg. Arpa Garay , and SVP & U.S. Market Johannes Jacobus Oosthuizen .

Merck & Co Inc (MRK) Insider Trades Summary

Over the past 18 months, Joseph Romanelli made 4 insider transaction in Merck & Co Inc (MRK) with a net sale of 4,715. Other recent insider transactions involving Merck & Co Inc (MRK) include a net sale of 133,401 shares made by Steven Mizell , a net sale of 2,172,853 shares made by Kenneth C Frazier , and a net sale of 318,341 shares made by Sanat Chattopadhyay .

In summary, during the past 3 months, insiders sold 8,839 shares of Merck & Co Inc (MRK) in total and bought 0 shares, with a net sale of 8,839 shares. During the past 18 months, 3,613,019 shares of Merck & Co Inc (MRK) were sold and 409 shares were bought by its insiders, resulting in a net sale of 3,612,610 shares.

Merck & Co Inc (MRK)'s detailed insider trading history can be found in Insider Trading Tracker table.


Merck & Co Inc Insider Transactions

No Available Data

Joseph Romanelli Mailing Address

Above is the net worth, insider trading, and ownership report for Joseph Romanelli. You might contact Joseph Romanelli via mailing address: 126 East Lincoln Avenue, Rahway Nj 07065.

Discussions on Joseph Romanelli

No discussions yet.